Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 09 Mar 2026 for Viridian Therapeutics, Inc.\DE, €52k.
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
Seth Harmon: trading record in brief
Seth Harmon appears in our data through filings on Viridian Therapeutics, Inc.\DE shares, published by SEC (Form 4). The record holds 3 filings, all for trades on 3 March 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 9 March 2026, the filings show a share grant worth €52k in Viridian Therapeutics, Inc.\DE. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Seth Harmon
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
2,031 shares@ US$30.19100.0% of flowCommon StockSEC:0001193125-26-099023:0
2,091 shares@ US$29.3250.0% of flowCommon StockSEC:0001193125-26-092071:1
6,267 sharesCommon StockSEC:0001193125-26-092071:0
3 of 3 declarations
